Loading…
Inhibrx Biosciences, Inc. is projected to rise to $124.11 by 2027, a +20% move from its current price of $103.00. INBX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $97.71 | $103.04 | $108.67 | +0.04% |
| May 30 | $95.62 | $103.09 | $111.14 | +0.08% |
| May 31 | $94.05 | $103.13 | $113.08 | +0.12% |
| Jun 1 | $92.76 | $103.17 | $114.75 | +0.17% |
| Jun 2 | $91.64 | $103.21 | $116.25 | +0.21% |
| Jun 3 | $90.65 | $103.26 | $117.62 | +0.25% |
| Jun 4 | $89.74 | $103.30 | $118.91 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $89.74 | $103.30 | $118.91 | +0.29% |
| Week 2 | $84.91 | $103.60 | $126.41 | +0.58% |
| Week 3 | $81.43 | $103.90 | $132.58 | +0.88% |
| Week 4 | $78.65 | $104.21 | $138.07 | +1.17% |
| Week 5 | $76.30 | $104.51 | $143.15 | +1.47% |
| Week 6 | $74.26 | $104.82 | $147.95 | +1.76% |
| Week 7 | $72.45 | $105.12 | $152.53 | +2.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops biologic therapeutics for people with life-threatening conditions.
Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma.
Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
INBX is currently priced at $101.32 per share.
It has a market capitalization of $1.49B and is ranked 2238 by market cap.
The 30-day range is $70.54 to $145.53, reflecting a near-term trading band.
Forecasts point to a rising price path with year-by-year averages: 2026 avg $101.32, 2027 $122.16, 2028 $171.76, 2029 $230.39, 2030 $318.39, 2031 $347.82, 2032 $316.22, 2033 $391.06, 2034 $432.06, 2035 $535.99, 2040 $759.28, and 2050 $2,137.83. The associated ROIs include 0% in 2026, 20.6% in 2027, 69.5% in 2028, 127.4% in 2029, 214.2% in 2030, 243.3% in 2031, 212.1% in 2032, 286% in 2033, 326.4% in 2034, 429% in 2035, 649.4% in 2040, and 2010% in 2050. The sentiment in the forecast is bullish across years, with neutral read for 2026.
A major floor 51.8% below — a decisive break under it would weaken the trend.
The nearest floor, 20.0% below — buyers have tended to step in here.
The nearest ceiling, 37.7% above — a clean break opens room to run.
A major ceiling 63.6% above — clearing it would confirm fresh momentum.
Key INBX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INBX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $106.35 | Sell | $105.94 | Sell |
| MA 10 | $108.98 | Sell | $109.21 | Sell |
| MA 20 | $118.28 | Sell | $110.63 | Sell |
| MA 50 | $95.17 | Buy | $101.26 | Buy |
| MA 100 | $85.73 | Buy | $89.46 | Buy |
| MA 200 | $69.54 | Buy | $72.86 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.96 | Neutral |
| Stoch RSI (14) | 6.43 | Buy |
| CCI (20) | -99.26 | Neutral |
| Williams %R (14) | -94.91 | Info |
| MACD (12,26,9) | -3.63 | Sell |
| ROC (12) | -23.33 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 5.09 | Buy |
| TRIX (15) | 0.73 | Buy |
| Awesome (5,34) | -3.21 | Sell |
| Ultimate (7,14,28) | 38.95 | Neutral |
| Momentum (10) | -5.65 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 103.68 | Sell |
| ADX (14) | 19.61 | Neutral |
| ATR (14) | 5.57 | Info |
The RSI (14) is 40, and the 50-day simple moving average is $93.73 with the 200-day simple moving average at $68.70.
Support is at $77.46 and resistance at $141.84. The 30-day price range runs from $70.54 to $145.53.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $58.39 | $103.00 | $157.91 | 0% | Neutral | |
| $89.39 | $124.11 | $186.45 | +20% | Bullish | |
| $118.75 | $174.92 | $279.31 | +70% | Bullish | |
| $151.44 | $234.75 | $392.98 | +128% | Bullish | |
| $196.84 | $319.66 | $556.55 | +210% | Bullish | |
| $207.65 | $352.25 | $634.44 | +242% | Bullish | |
| $183.18 | $323.96 | $601.33 | +215% | Bullish | |
| $212.98 | $392.10 | $747.74 | +281% | Bullish | |
| $230.71 | $441.69 | $863.35 | +329% | Bullish | |
| $277.52 | $552.06 | $1,103.88 | +436% | Bullish | |
| $350.68 | $779.29 | $1,710.95 | +657% | Bullish | |
| $978.33 | $2,174.06 | $5,000.34 | +20.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $58.39 | $103.00 | $121.28 | +0.00% |
| June 2026 | $84.53 | $101.36 | $125.92 | -1.60% |
| July 2026 | $87.74 | $106.99 | $136.31 | +5.55% |
| August 2026 | $85.64 | $105.82 | $137.43 | -1.09% |
| September 2026 | $83.61 | $104.45 | $137.77 | -1.29% |
| October 2026 | $89.62 | $113.11 | $151.29 | +8.29% |
| November 2026 | $93.68 | $119.30 | $161.51 | +5.47% |
| December 2026 | $89.77 | $115.32 | $157.91 | -3.34% |
Click any year to see its month-by-month INBX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INBX to range from $58.39 to $157.91 through 2026. The $103.00 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The INBX price prediction for 2027 points to an average of $124.11 (low $89.39, high $186.45) — a potential gain of +20% on today's $103.00. Buyers look set to stay in control over this stretch.
In 2028, INBX is projected to trade between $118.75 and $279.31, averaging $174.92 — a potential gain of +70% from today's $103.00. That is up +41% on the projected 2027 average. Momentum favours further upside here.
Inhibrx Biosciences, Inc.'s 2029 outlook centres on $234.75, within a $151.44 to $392.98 range. That is up +34% on the projected 2028 average. That marks a +128% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, INBX could reach as high as $556.55, with a base case around $319.66 and support toward $196.84 — roughly +210% from $103.00. Momentum favours further upside here.
Expect INBX to range from $207.65 to $634.44 through 2031. The $352.25 average target implies a +242% move from current prices. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The INBX price prediction for 2032 points to an average of $323.96 (low $183.18, high $601.33) — a potential gain of +215% on today's $103.00. Momentum favours further upside here.
In 2033, INBX is projected to trade between $212.98 and $747.74, averaging $392.10 — a potential gain of +281% from today's $103.00. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Inhibrx Biosciences, Inc.'s 2034 outlook centres on $441.69, within a $230.71 to $863.35 range. That is up +13% on the projected 2033 average. That marks a +329% change versus current levels. Momentum favours further upside here.
By 2035, INBX could reach as high as $1,103.88, with a base case around $552.06 and support toward $277.52 — roughly +436% from $103.00. Buyers look set to stay in control over this stretch.
Expect INBX to range from $350.68 to $1,710.95 through 2040. The $779.29 average target implies a +657% move from current prices. That is up +41% on the projected 2035 average. Momentum favours further upside here.
The INBX price prediction for 2050 points to an average of $2,174.06 (low $978.33, high $5,000.34) — a potential gain of +20.1x on today's $103.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in INBX today (≈ 9.708738 INBX) could be worth
$21,107.39
+$20,107.39 (+2011%) by 2050 · US Dollar
Based on the average projected INBX price of $2,174.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INBXwould be worth at today's price.
$1,000 invested in INBX on May 27, 2025 (≈ 76.161462 INBX) would be worth
$7,844.63
+$6,844.63 (+684.5%) today · 7.84× · US Dollar
Based on a INBX entry price of $13.13 vs. today's $103.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $110.01 | $936.28 | -6.4% |
| 1 month ago | $131.45 | $783.57 | -21.6% |
| 3 months ago | $77.23 | $1,333.68 | +33.4% |
| 6 months ago | $84.12 | $1,224.44 | +22.4% |
| 1 year ago | $13.13 | $7,844.63 | +684.5% |
| All time (2.0y) ago | $12.51 | $8,235.56 | +723.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INBX forecast.
Our base-case forecast reaches $210.00 around 2029.
Implied market cap at $210.00: $3.08B
The multi-year forecast shows a bullish trajectory with long-term averages rising from $101.32 in 2026 to $318.39 in 2030 and to $2,137.83 in 2050. The forecasted highs reach $1,073.84 in 2035, $1,670.49 in 2040, and $4,917.02 in 2050.
Forecasted averages include 2027 $122.16, 2028 $171.76, 2029 $230.39, 2031 $347.82, 2032 $316.22, 2033 $391.06, 2034 $432.06, 2035 $535.99, 2040 $759.28.
The projected ROIs climb to 214.2% in 2030, 649.4% in 2040, and 2010% in 2050. These figures are estimates and not guarantees; actual results may vary.
Tap a question to reveal the answer.
Avg $318.39, with a min of $195.62 and a max of $555.35.
Forecasts show bullish sentiment in years ahead with an avg price of $318.39 by 2030 and ROI of 214.2% in 2030; however these are estimates and not guarantees.
Yes. The forecast max prices reach $1,073.84 in 2035, $1,670.49 in 2040, and $4,917.02 in 2050.
Current price is $101.32 and market cap is $1.49B.
The 30-day range is $70.54 to $145.53.
Inhibrx Biosciences, Inc. Community Discussion
0Share your Inhibrx Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.